VISILIZUMAB Drug Record

  • VISILIZUMAB chembl:CHEMBL2108811

    Alternate Names:

    NUVION
    HUM291
    VISILIZUMAB
    HUM-291

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,immunosuppressant,for treatment of Chron's disease,for treatment of ulcerative colitis
    (0 More Sources)

    Publications:

  • VISILIZUMAB   CD3E

    Interaction Score: 4.12

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name Nuvion
    Mechanism of Interaction T-cell surface glycoprotein CD3 epsilon chain inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • VISILIZUMAB   CD3D

    Interaction Score: 2.94

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Nuvion
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • VISILIZUMAB   CD3G

    Interaction Score: 1.59

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Nuvion
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: VISILIZUMAB

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,immunosuppressant,for treatment of Chron's disease,for treatment of ulcerative colitis
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: Visilizumab

    • Version: 2020.06.01

    Alternate Names:
    D0OH8W TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2108811

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL2108811

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: